244 related articles for article (PubMed ID: 22258935)
1. Erythropoietin-coated ZP-microneedle transdermal system: preclinical formulation, stability, and delivery.
Peters EE; Ameri M; Wang X; Maa YF; Daddona PE
Pharm Res; 2012 Jun; 29(6):1618-26. PubMed ID: 22258935
[TBL] [Abstract][Full Text] [Related]
2. Human Growth Hormone Delivery with a Microneedle Transdermal System: Preclinical Formulation, Stability, Delivery and PK of Therapeutically Relevant Doses.
Ameri M; Kadkhodayan M; Nguyen J; Bravo JA; Su R; Chan K; Samiee A; Daddona PE
Pharmaceutics; 2014 May; 6(2):220-34. PubMed ID: 24838219
[TBL] [Abstract][Full Text] [Related]
3. Delivery of salmon calcitonin using a microneedle patch.
Tas C; Mansoor S; Kalluri H; Zarnitsyn VG; Choi SO; Banga AK; Prausnitz MR
Int J Pharm; 2012 Feb; 423(2):257-63. PubMed ID: 22172290
[TBL] [Abstract][Full Text] [Related]
4. Safety and biosimilarity of ior(®) EPOCIM compared with Eprex(®) based on toxicologic, pharmacodynamic, and pharmacokinetic studies in the Sprague-Dawley rat.
Pucaj K; Riddle K; Taylor SR; Ledon N; Bolger GT
J Pharm Sci; 2014 Nov; 103(11):3432-3441. PubMed ID: 25250536
[TBL] [Abstract][Full Text] [Related]
5. Coating solid dispersions on microneedles via a molten dip-coating method: development and in vitro evaluation for transdermal delivery of a water-insoluble drug.
Ma Y; Gill HS
J Pharm Sci; 2014 Nov; 103(11):3621-3630. PubMed ID: 25213295
[TBL] [Abstract][Full Text] [Related]
6. Effect of fiber length of carbon nanotubes on the absorption of erythropoietin from rat small intestine.
Ito Y; Venkatesan N; Hirako N; Sugioka N; Takada K
Int J Pharm; 2007 Jun; 337(1-2):357-60. PubMed ID: 17270373
[TBL] [Abstract][Full Text] [Related]
7. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of coated polymer microneedles for transdermal drug delivery.
Chen Y; Chen BZ; Wang QL; Jin X; Guo XD
J Control Release; 2017 Nov; 265():14-21. PubMed ID: 28344014
[TBL] [Abstract][Full Text] [Related]
9. Coated microneedles for transdermal delivery of a potent pharmaceutical peptide.
Kapoor Y; Milewski M; Dick L; Zhang J; Bothe JR; Gehrt M; Manser K; Nissley B; Petrescu I; Johnson P; Burton S; Moseman J; Hua V; Grunewald T; Tomai M; Smith R
Biomed Microdevices; 2019 Dec; 22(1):7. PubMed ID: 31845070
[TBL] [Abstract][Full Text] [Related]
10. Semi-mechanistic Pharmacokinetic/Pharmacodynamic model of three pegylated rHuEPO and ior®EPOCIM in New Zealand rabbits.
Reynaldo-Fernández G; Solozábal J; Amaro D; Fernández-Sánchez EM; Rodríguez-Vera L; Bermejo M; Mangas-Sanjuan V; Troconiz IF
Eur J Pharm Sci; 2018 Jul; 120():123-132. PubMed ID: 29729414
[TBL] [Abstract][Full Text] [Related]
11. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
Shah V; Choudhury BK
AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
[TBL] [Abstract][Full Text] [Related]
12. Formulation Approach that Enables the Coating of a Stable Influenza Vaccine on a Transdermal Microneedle Patch.
Ameri M; Ao Y; Lewis H
AAPS PharmSciTech; 2021 Jun; 22(5):175. PubMed ID: 34114100
[TBL] [Abstract][Full Text] [Related]
13. Coating formulations for microneedles.
Gill HS; Prausnitz MR
Pharm Res; 2007 Jul; 24(7):1369-80. PubMed ID: 17385011
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.
Katsumi H; Liu S; Tanaka Y; Hitomi K; Hayashi R; Hirai Y; Kusamori K; Quan YS; Kamiyama F; Sakane T; Yamamoto A
J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424
[TBL] [Abstract][Full Text] [Related]
15. Touch-actuated microneedle array patch for closed-loop transdermal drug delivery.
Yang J; Chen Z; Ye R; Li J; Lin Y; Gao J; Ren L; Liu B; Jiang L
Drug Deliv; 2018 Nov; 25(1):1728-1739. PubMed ID: 30182757
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic and pharmacodynamic model-based comparability assessment of a recombinant human Epoetin Alfa and the Biosimilar HX575.
Yan X; Lowe PJ; Fink M; Berghout A; Balser S; Krzyzanski W
J Clin Pharmacol; 2012 Nov; 52(11):1624-44. PubMed ID: 22162538
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone PTH(1-34) formulation that enables uniform coating on a novel transdermal microprojection delivery system.
Ameri M; Fan SC; Maa YF
Pharm Res; 2010 Feb; 27(2):303-13. PubMed ID: 20013035
[TBL] [Abstract][Full Text] [Related]
18. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
Xie Y; Xu B; Gao Y
Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
[TBL] [Abstract][Full Text] [Related]
19. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
[TBL] [Abstract][Full Text] [Related]
20. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate.
Tekko IA; Chen G; Domínguez-Robles J; Thakur RRS; Hamdan IMN; Vora L; Larrañeta E; McElnay JC; McCarthy HO; Rooney M; Donnelly RF
Int J Pharm; 2020 Aug; 586():119580. PubMed ID: 32593650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
